产品标题 |
产品货号 |
产品规格 |
厂家 |
Human RNA: Colon; Crohns disease from ORIGENE TECHNOLOGIES | CR560665 | 5 ug | ORIGENE TECHNOLOGIES |
Similar to ankyrin repeat domain 20A (MGC26718) from ORIGENE TECHNOLOGIES | LY422279 | 100 ug | ORIGENE TECHNOLOGIES |
Similar to cell division cycle 42, transcript variant 3 (LOC643751) from ORIGENE TECHNOLOGIES | TP303829 | 20 ug | ORIGENE TECHNOLOGIES |
Similar to CG32736-PA (LOC440957) from ORIGENE TECHNOLOGIES | LY426629 | 100 ug | ORIGENE TECHNOLOGIES |
Similar to CG32662-PA (MGC88374) from ORIGENE TECHNOLOGIES | LY423731 | 100 ug | ORIGENE TECHNOLOGIES |
Similar to CTAGE6 (LOC441294) from ORIGENE TECHNOLOGIES | LY423371 | 100 ug | ORIGENE TECHNOLOGIES |
Similar to Cytochrome c, somatic (MGC12965) from ORIGENE TECHNOLOGIES | LY404904 | 100 ug | ORIGENE TECHNOLOGIES |
Similar to D-dopachrome tautomerase (LOC391322) from ORIGENE TECHNOLOGIES | LY428584 | 100 ug | ORIGENE TECHNOLOGIES |
Similar to eukaryotic translation initiation factor 4H isoform 2, transcript variant 6 (LOC653994) from ORIGENE TECHNOLOGIES | TP302945 | 20 ug | ORIGENE TECHNOLOGIES |
Similar to hepatitis C virus core-binding protein 6; cervical cancer oncogene 3 (LOC388965) from ORIGENE TECHNOLOGIES | LY423001 | 100 ug | ORIGENE TECHNOLOGIES |
Similar to hypothetical protein FLJ25976 (FLJ25363) from ORIGENE TECHNOLOGIES | LY428941 | 100 ug | ORIGENE TECHNOLOGIES |
Similar to peptidylprolyl isomerase A isoform 1 (LOC654188) from ORIGENE TECHNOLOGIES | TP302752 | 20 ug | ORIGENE TECHNOLOGIES |
Similar to RPL23AP7 protein (MGC70863), transcript variant 1 from ORIGENE TECHNOLOGIES | LY404241 | 100 ug | ORIGENE TECHNOLOGIES |
Similar to RPL23AP7 protein (MGC70863), transcript variant 1 from ORIGENE TECHNOLOGIES | LY430932 | 100 ug | ORIGENE TECHNOLOGIES |
Similar to RPL23AP7 protein (MGC70863), transcript variant 2 from ORIGENE TECHNOLOGIES | LY404385 | 100 ug | ORIGENE TECHNOLOGIES |
Similar to solute carrier family 35, member E2 (LOC728661) from ORIGENE TECHNOLOGIES | LY426330 | 100 ug | ORIGENE TECHNOLOGIES |
Similar to 60S ribosomal protein L21 (RPL21_17_477) from ORIGENE TECHNOLOGIES | LY423267 | 100 ug | ORIGENE TECHNOLOGIES |
SIM2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN416257 | 1 kit | ORIGENE TECHNOLOGIES |
SIM1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN422805 | 1 kit | ORIGENE TECHNOLOGIES |
Sim1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515789 | 1 kit | ORIGENE TECHNOLOGIES |
Sim2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515790 | 1 kit | ORIGENE TECHNOLOGIES |
Human RAP2B, member of RAS oncogene family (RAP2B) from ORIGENE TECHNOLOGIES | TP304287 | 20 ug | ORIGENE TECHNOLOGIES |
Human RAP1B, member of RAS oncogene family (RAP1B), transcript variant 2 from ORIGENE TECHNOLOGIES | TP321793 | 20 ug | ORIGENE TECHNOLOGIES |
Human RAP1B, member of RAS oncogene family (RAP1B), transcript variant 1 from ORIGENE TECHNOLOGIES | TP760456 | 50 ug | ORIGENE TECHNOLOGIES |
Hyaluronan binding protein 4 (HABP4) from ORIGENE TECHNOLOGIES | LY415386 | 100 ug | ORIGENE TECHNOLOGIES |
Hyaluronan-mediated motility receptor (RHAMM) (HMMR), transcript variant 3 from ORIGENE TECHNOLOGIES | LY415729 | 100 ug | ORIGENE TECHNOLOGIES |
Hyaluronan synthase 1 (HAS1) from ORIGENE TECHNOLOGIES | LY419883 | 100 ug | ORIGENE TECHNOLOGIES |
Hyaluronan synthase 3 (HAS3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417376 | 100 ug | ORIGENE TECHNOLOGIES |
Hyaluronan synthase 3 (HAS3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY408564 | 100 ug | ORIGENE TECHNOLOGIES |
Vascular endothelial growth factor A (VEGFA), transcript variant 1 from ORIGENE TECHNOLOGIES | LY422435 | 100 ug | ORIGENE TECHNOLOGIES |
Vascular endothelial growth factor A (VEGFA), transcript variant 1 from ORIGENE TECHNOLOGIES | LY425496 | 100 ug | ORIGENE TECHNOLOGIES |
Vascular endothelial growth factor A (VEGFA), transcript variant 6 from ORIGENE TECHNOLOGIES | LY422439 | 100 ug | ORIGENE TECHNOLOGIES |
Vascular endothelial growth factor A (VEGFA), transcript variant 7 from ORIGENE TECHNOLOGIES | LY422419 | 100 ug | ORIGENE TECHNOLOGIES |
Vascular endothelial growth factor A (VEGFA), transcript variant 7 from ORIGENE TECHNOLOGIES | LY425581 | 100 ug | ORIGENE TECHNOLOGIES |
Vascular endothelial growth factor B (VEGFB) from ORIGENE TECHNOLOGIES | LY418732 | 100 ug | ORIGENE TECHNOLOGIES |
TP53AIP1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN410110 | 1 kit | ORIGENE TECHNOLOGIES |
SLMAP - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN421364 | 1 kit | ORIGENE TECHNOLOGIES |
Slmap - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516256 | 1 kit | ORIGENE TECHNOLOGIES |
SLMO2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN401029 | 1 kit | ORIGENE TECHNOLOGIES |
Slmo1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516257 | 1 kit | ORIGENE TECHNOLOGIES |
Slmo2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516258 | 1 kit | ORIGENE TECHNOLOGIES |
SLN - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN402706 | 1 kit | ORIGENE TECHNOLOGIES |
Sln - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516259 | 1 kit | ORIGENE TECHNOLOGIES |
Slowmo homolog 2 (Drosophila) (SLMO2) from ORIGENE TECHNOLOGIES | LY414226 | 100 ug | ORIGENE TECHNOLOGIES |
Slowmo homolog 1 (Drosophila) (SLMO1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY428072 | 100 ug | ORIGENE TECHNOLOGIES |
Slowmo homolog 1 (Drosophila) (SLMO1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY416568 | 100 ug | ORIGENE TECHNOLOGIES |
Slowmo homolog 1 (Drosophila) (SLMO1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY428073 | 100 ug | ORIGENE TECHNOLOGIES |
Formiminotransferase cyclodeaminase (FTCD), transcript variant A from ORIGENE TECHNOLOGIES | LY430967 | 100 ug | ORIGENE TECHNOLOGIES |
Formiminotransferase cyclodeaminase (FTCD), transcript variant A from ORIGENE TECHNOLOGIES | LY404121 | 100 ug | ORIGENE TECHNOLOGIES |
Formiminotransferase cyclodeaminase (FTCD), transcript variant B from ORIGENE TECHNOLOGIES | LY416500 | 100 ug | ORIGENE TECHNOLOGIES |